|
IQGAP3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.6383565311412E-12 |
| Normal-vs-Stage2 |
3.101700E-02 |
| Normal-vs-Stage3 |
1.64900999999329E-05 |
| Normal-vs-Stage4 |
1.385650E-02 |
| Stage1-vs-Stage2 |
3.876800E-01 |
| Stage1-vs-Stage3 |
9.443100E-04 |
| Stage1-vs-Stage4 |
6.116400E-02 |
| Stage2-vs-Stage3 |
7.047900E-02 |
| Stage2-vs-Stage4 |
1.605000E-01 |
| Stage3-vs-Stage4 |
9.636400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62747593179802E-12 |
| Normal-vs-AfricanAmerican |
2.67840000001129E-06 |
| Normal-vs-Asian |
6.336500E-02 |
| Caucasian-vs-AfricanAmerican |
3.270600E-01 |
| Caucasian-vs-Asian |
3.684400E-01 |
| AfricanAmerican-vs-Asian |
1.413240E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.66373598126302E-15 |
| Normal-vs-Female |
3.66140000540582E-08 |
| Male-vs-Female |
1.542110E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.52969999999542E-05 |
| Normal-vs-Extreme_Weight |
9.02490000509459E-08 |
| Normal-vs-Obese |
2.127900000648E-08 |
| Normal-vs-Extreme_Obese |
9.005000E-04 |
| Normal_Weight-vs-Extreme_Weight |
7.862000E-02 |
| Normal_Weight-vs-Obese |
7.815200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.544800E-03 |
| Extreme_Weight-vs-Obese |
4.363600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.266200E-02 |
| Obese-vs-Extreme_Obese |
1.844290E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.437000E-04 |
| Normal-vs-Age(41-60Yrs) |
3.97348820513344E-13 |
| Normal-vs-Age(61-80Yrs) |
3.10300000139208E-08 |
| Normal-vs-Age(81-100Yrs) |
2.067600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.318000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.161000E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.735000E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.438600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.375600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.250000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.42139666492858E-11 |
| Normal-VS-Type2 PRCC |
3.506900000394E-07 |
| Normal-VS-KIRP CIMP |
4.160100E-04 |
| Normal-VS-Unclassified PRCC |
1.240610E-04 |
| Type1 PRCC-VS-Type2 PRCC |
4.438300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.822260E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.249200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.249720E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
4.132000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.097700E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.35590000003039E-06 |
| Normal-vs-N1 |
3.70149999999736E-05 |
| Normal-vs-N2 |
9.127700E-02 |
| N0-vs-N1 |
1.843610E-03 |
| N0-vs-N2 |
1.726370E-02 |
| N1-vs-N2 |
7.833400E-01 |
|
|
